Combination of IGF‑1 gene manipulation and 5‑AZA treatment promotes differentiation of mesenchymal stem cells into cardiomyocyte‑like cells

Li,Jun; Zhu,Kai; Wang,Yulin; Zheng,Jiayu; Guo,Changfa; Lai,Hao; Wang,Chunsheng

doi:10.3892/mmr.2014.2812

Combination of IGF‑1 gene manipulation and 5‑AZA treatment promotes differentiation of mesenchymal stem cells into cardiomyocyte‑like cells

Authors:
- Jun Li
- Kai Zhu
- Yulin Wang
- Jiayu Zheng
- Changfa Guo
- Hao Lai
- Chunsheng Wang
View Affiliations

Affiliations: Department of Cardiac Surgery, Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China
Published online on: October 29, 2014 https://doi.org/10.3892/mmr.2014.2812
Pages: 815-820
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mesenchymal stem cell (MSC) transplantation has been proposed as a promising therapeutic strategy for ischemic myocardium repair following myocardial infarction. Differentiation of MSCs into cardiomyocyte‑like cells prior to cell transplantation is advantageous in improving their potential clinical benefits for cardiac repair. In the present study, we isolated and cultured porcine MSCs and evaluated the synergistic effect of 5‑azacytidine (5‑AZA) treatment and insulin‑like growth factor‑1 (IGF‑1) gene manipulation on MSC differentiation into cardiomyocyte‑like cells. Our results demonstrated that 5‑AZA treatment alone induced a limited cardiomyocyte‑like differentiation effect in vitro. Overexpression of the IGF‑1 gene in MSCs improved the induction effect of 5‑AZA, while knockdown of the IGF‑1 gene attenuated the differentiation. These results suggest that IGF‑1 is a significant stimulus affecting the cardiomyocyte‑like differentiation of porcine MSCs. In addition, the combination of IGF‑1 gene manipulation and 5‑AZA treatment provides a new strategy to obtain more committed differentiated cardiomyocyte‑like cells from porcine MSCs prior to cell transplantation.

View Figures

View References

1	Buckberg G, Athanasuleas C and Conte J: Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol. 9:703–716. 2012. View Article : Google Scholar : PubMed/NCBI
2	Gnecchi M, Danieli P and Cervio E: Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol. 57:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
3	Williams AR and Hare JM: Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI
4	Dimmeler S and Zeiher AM: Cell therapy of acute myocardial infarction: open questions. Cardiology. 113:155–160. 2009. View Article : Google Scholar : PubMed/NCBI
5	Hill JM, Dick AJ, Raman VK, et al: Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 108:1009–1014. 2003. View Article : Google Scholar : PubMed/NCBI
6	Zhao Y, Li T, Wei X, et al: Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction. Stem Cells Transl Med. 1:685–695. 2012. View Article : Google Scholar : PubMed/NCBI
7	Li H, Yu B, Zhang Y, et al: Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem Biophys Res Commun. 341:320–325. 2006. View Article : Google Scholar : PubMed/NCBI
8	Li H, Zuo S, Pasha Z, et al: GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4. Cytotherapy. 13:1057–1065. 2011. View Article : Google Scholar : PubMed/NCBI
9	Haghani K, Bakhtiyari S and Nouri AM: In vitro study of the differentiation of bone marrow stromal cells into cardiomyocyte-like cells. Mol Cell Biochem. 361:315–320. 2012. View Article : Google Scholar
10	Burlacu A: Can 5-Azacytidine convert the adult stem cells into cardiomyocytes? A brief overview. Arch Physiol Biochem. 112:260–264. 2006. View Article : Google Scholar : PubMed/NCBI
11	Lai NC, Tang T, Gao MH, et al: Improved function of the failing rat heart by regulated expression of insulin-like growth factor I via intramuscular gene transfer. Hum Gene Ther. 23:255–261. 2012. View Article : Google Scholar :
12	Cai B, Li J, Wang J, et al: MicroRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Stem Cells. 30:1746–1755. 2012. View Article : Google Scholar : PubMed/NCBI
13	Xing Y, Lv A, Wang L, et al: The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem. 360:279–287. 2012. View Article : Google Scholar
14	Zhao JW, Zhang MR, Ji QY, et al: The role of slingshot-1 L (SSH1L) in the differentiation of human bone marrow mesenchymal stem cells into cardiomyocyte-like cells. Molecules. 17:14975–14994. 2012. View Article : Google Scholar : PubMed/NCBI
15	Samper E, Diez-Juan A, Montero JA, et al: Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev. 9:266–280. 2013. View Article : Google Scholar
16	Tomita S, Li R-K, Weisel RD, et al: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 100:II247–II256. 1999. View Article : Google Scholar : PubMed/NCBI
17	Liu Y, Song J, Liu W, et al: Growth and differentiation of rat bone marrow stromal cells: does 5-AZA trigger their cardiomyogenic differentiation? Cardiovasc Res. 58:460–468. 2003. View Article : Google Scholar : PubMed/NCBI
18	Li Q, Li B, Wang X, et al: Overexpression of insulin-like growth factor I in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 100:1991–1999. 1997. View Article : Google Scholar : PubMed/NCBI
19	Lee WL, Chen JW, Ting CT, et al: Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology. 140:4831–4840. 1999.PubMed/NCBI
20	Buerke M, Murohara T, Skurk C, et al: Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 92:8031–8035. 1995. View Article : Google Scholar : PubMed/NCBI
21	Muguruma Y, Reyes M, Nakamura Y, et al: In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. Exp Hematol. 31:1323–1330. 2003. View Article : Google Scholar : PubMed/NCBI
22	Bartunek J, Croissant JD, Wijns W, et al: Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol. 292:H1095–H1104. 2007. View Article : Google Scholar
23	Rommel C, Bodine SC, Clarke BA, et al: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat Cell Biol. 3:1009–1013. 2001. View Article : Google Scholar : PubMed/NCBI
24	Liu W, Liu Y and Lowe WL Jr: The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells. Endocrinology. 142:1710–1719. 2001.PubMed/NCBI